• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI JUGULAR SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI JUGULAR SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number DL900J
Device Problem Difficult to Remove (1528)
Patient Problem Pain (1994)
Event Date 11/22/2017
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately one year and eight months later, filter retrieval was scheduled, attempted to snare the inferior vena cava filter percutaneously but after a prolonged attempt filter removal was unsuccessful, and the filter was remained in place.This was apparently because the hook of the filter was either embedded into the wall of the inferior vena cava or covered with fibrin sheath.After ten days, patient was reported abdominal and lower back pain one day after attempted filter removal and that has been persistent since that time.A computerized tomography scan of abdomen and pelvis showed phlebitis of inferior vena cava and bilateral iliac veins and reported thrombus in the inferior vena cava filter.Moderate nonspecific retroperitoneal fat at level of inferior vena cava filter and extended to origin of bilateral external iliac arteries, that was might be related to recent attempt made at inferior vena cava catheter removal and resultant infection was suggested.Therefore, the investigation is confirmed for alleged retrieval difficulties.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 10/2018).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter unable to be retrieved.The device has not been removed after unsuccessful percutaneous removal attempt.The patient reportedly experienced abdominal and back pain; however, the current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI JUGULAR SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key10300789
MDR Text Key199640165
Report Number2020394-2020-04710
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040795
UDI-Public(01)00801741040795
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2018
Device Model NumberDL900J
Device Catalogue NumberDL900J
Device Lot NumberGFZJ0094
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/26/2020
Initial Date FDA Received07/21/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ALUM/MAGNESIUM/SIMETHICONE, MAGNESIUM HYDROXIDE; FAMOTIDINE, VANCOMYCIN; HEPARIN, ELIQUIS, AMLODIPINE, CARVEDILOL; LORAZEPAM, SODIUM CHLORIDE, DOCUSATE SODIUM; ONDANSETRON, ACETAMINOPHEN, BISACODYL; PIPERACILLIN/TAZOBACTAM, NICOTINE, OXYCODONE; WARFARIN, CLONIDINE, LABETALOL, HYDRALAZINE
Patient Outcome(s) Other;
Patient Age53 YR
Patient Weight69
-
-